Knight TherapeuticsFRA:04K 73 Days Inventory is 158.35 as of Mar. 2026, which is 18% below its 10-year median of 193.72. GuruFocus rates FRA:04K with a GF Score™ of 73/100 and a GF Value™ of €5.27. The stock has 6 warning signs investors should review. Among 919 Drug Manufacturers companies, Knight Therapeutics ranks worse than 59.96% on this metric.
The historical rank and industry rank for Knight Therapeutics's Days Inventory or its related term are showing as below:
FRA:04K'
s Days Inventory Range Over the Past 10 Years
Min: 174.25 Med: 193.72 Max: 639.69
Current: 188.07
During the past 13 years, Knight Therapeutics's highest Days Inventory was 639.69. The lowest was 174.25. And the median was 193.72.
FRA:04K's Days Inventory is ranked worse than 59.96% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs FRA:04K: 188.07
Knight Therapeutics's Days Inventory
declined
from Mar. 2025 (211.79) to Mar. 2026 (158.35).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Knight Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Knight Therapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.93.
Knight Therapeutics (FRA:04K) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Knight Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Knight Therapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Knight Therapeutics Days Inventory Related Terms
Knight Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for Knight Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Knight Therapeutics Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Knight Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Knight Therapeutics (FRA:04K) has a Days Inventory of 158.35 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Knight Therapeutics and its competitors. This is 18% below median its historical median of 193.72. Over the past decade, Knight Therapeutics' Days Inventory has ranged from 174.25 to 639.69. According to the industry distribution chart, Knight Therapeutics ranks #551 out of 919 companies in the Drug Manufacturers industry, placing it in the top 60%.
Is Knight Therapeutics' Days Inventory too high?
Knight Therapeutics' current Days Inventory of 158.35 is 18% below median its 10-year median of 193.72. Over the past 10 years, this metric has ranged from a low of 174.25 to a high of 639.69. The Drug Manufacturers industry median Days Inventory is 164.48. Knight Therapeutics' value of 158.35 is 3.7% below this industry median. Based on the distribution chart, Knight Therapeutics ranks #551 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Knight Therapeutics has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Knight Therapeutics' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Knight Therapeutics ranks #551 out of 919 companies for Days Inventory. This places Knight Therapeutics in the lower half of its industry. The industry median Days Inventory is 164.48. Knight Therapeutics' value of 158.35 is 3.7% below this benchmark. Historically, Knight Therapeutics' own Days Inventory has ranged from 174.25 to 639.69 over the past decade. While the company's 10-year median is 193.72 vs. the industry median of 164.48, Knight Therapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Knight Therapeutics's current Days Inventory of 158.35 is 3.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Knight Therapeutics and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Knight Therapeutics's current Days Inventory is 158.35, which is 18% below median its own 10-year median of 193.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Knight Therapeutics stock overvalued right now?
Knight Therapeutics (FRA:04K) has a current Days Inventory of 158.35. The stock's GF Value™ is €5.27, compared to a current price of €6.10 — trading 15.7% above its estimated fair value. The current Days Inventory is 158.35, which is 18% below median its 10-year median of 193.72 and 3.7% below the Drug Manufacturers industry median of 164.48. Knight Therapeutics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Knight Therapeutics (FRA:04K), the current Days Inventory is 158.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Knight Therapeutics (FRA:04K) Overvalued in 2026?
Based on GuruFocus' analysis, Knight Therapeutics stock appears to be overvalued.
The current stock price of €6.10 is trading 15.7% above its estimated GF Value™ of €5.27.
Key valuation signals for FRA:04K:
Days Inventory: 158.35 (18% below median its 10-year median of 193.72)
GF Value™: €5.27 vs. price of €6.10 (15.7% above fair value)
Industry Position: 3.7% below the Drug Manufacturers median (#551 of 919)
No single metric tells the full story. See the FRA:04K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceuticalproducts. and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets. The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically, the company generates revenue from Brazil, Canada, Colombia, Argentina, Mexico, Rest of LATAM, and Others, with the majority revenue generated from the Brazil region.
73GF Score
Get the complete analysis for FRA:04K
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:04K has been successfully added to your 
